REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,822,018 | +20.8% | 1,419,900 | 0.0% | 14.38% | -12.1% |
| Q3 2022 | $28,000,000 | +1.2% | 1,419,900 | 0.0% | 16.36% | -10.1% |
| Q2 2022 | $27,674,000 | -23.6% | 1,419,900 | 0.0% | 18.20% | +37.1% |
| Q1 2022 | $36,222,000 | +1.4% | 1,419,900 | 0.0% | 13.27% | +29.1% |
| Q4 2021 | $35,739,000 | -8.5% | 1,419,900 | 0.0% | 10.28% | +16.0% |
| Q3 2021 | $39,061,000 | -13.3% | 1,419,900 | 0.0% | 8.86% | -58.7% |
| Q2 2021 | $45,068,000 | -30.8% | 1,419,900 | 0.0% | 21.46% | -10.6% |
| Q1 2021 | $65,145,000 | +15.9% | 1,419,900 | 0.0% | 24.00% | +33.1% |
| Q4 2020 | $56,214,000 | +13.8% | 1,419,900 | 0.0% | 18.03% | +6.0% |
| Q3 2020 | $49,413,000 | +10.2% | 1,419,900 | 0.0% | 17.01% | -17.6% |
| Q2 2020 | $44,826,000 | +44.1% | 1,419,900 | 0.0% | 20.65% | -27.4% |
| Q1 2020 | $31,110,000 | – | 1,419,900 | – | 28.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |